Nirsevimab

A4DAB181 | Infectious diseases | Approved
Respiratory Syncytial Virus
G1 / IgG1
AIMM Therapeutics MedImmune
Approved
Whole mAb
MEDI 8897 MEDI-8897 MEDI8897 SP 0232 SP0232 SP-0232 SP-232 SP232 SP 232
6
Avg A4D Score
-0.641
Score Range
-0.67 to -0.58
Structures
15
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity

Associated Structural Profiles Level 2

Structure ID Source PDB Seq. Identity Avg. A4D Score pH (Min Agg.) pH (Max Agg.) Score CDR Score non-CDR
A4DAB181_6s3d_C_D 6s3d 96% -0.6575 6.5 4.0 -0.1093 -0.7367
A4DAB181_5udc_H_L 5udc 100% -0.6432 7.0 4.0 -0.1214 -0.717
A4DAB181_5udd_N_T 5udd 100% -0.6637 7.0 4.0 -0.162 -0.7339
A4DAB181_5udd_K_Q 5udd 100% -0.6321 6.5 4.0 -0.0806 -0.7094
A4DAB181_6s3d_E_F 6s3d 96% -0.6407 6.5 4.0 -0.0217 -0.7299
A4DAB181_5udd_O_U 5udd 100% -0.6583 6.5 4.0 -0.129 -0.7339
A4DAB181_4jha_H_L 4jha 96% -0.618 6.5 4.0 0.0469 -0.7097
A4DAB181_5udd_M_S 5udd 100% -0.6571 6.5 4.0 -0.0838 -0.7372
A4DAB181_6s3d_H_L 6s3d 96% -0.5805 6.5 4.0 -0.0273 -0.6597
A4DAB181_6s3d_A_B 6s3d 96% -0.6108 6.5 4.0 -0.0587 -0.6901
A4DAB181_5udd_J_P 5udd 100% -0.6474 6.5 4.0 -0.103 -0.7227
A4DAB181_4jhw_H_L 4jhw 96% -0.6257 6.5 4.0 -0.0848 -0.7003
A4DAB181_5udd_L_R 5udd 100% -0.6648 6.5 4.0 -0.1694 -0.7341
A4DAB181_5udc_E_G 5udc 100% -0.6718 6.5 4.0 -0.1279 -0.7477
A4DAB181_5udc_B_C 5udc 100% -0.6441 7.0 4.0 -0.0946 -0.7216